Have we reached ‘peak HEOR’?

That is the title of my guest column at The Evidence Base. An excerpt is below: Multiple indicators suggest that health economics and outcomes research (HEOR) faces unprecedented challenges to its traditional role in pharmaceutical value demonstration. Yet these apparent threats may signal evolution rather than decline – if the field can adapt to serve…

Read More

Senators Press Deloitte, Other Contractors on Errors in Medicaid Eligibility Systems

Senators have launched an inquiry into companies paid billions in taxpayer dollars to build eligibility systems for Medicaid, expressing concern that error-riddled technology and looming work requirements “will cause Americans to lose Medicaid coverage to this bureaucratic maze.” The letters, dated Oct. 10, were sent to four companies and follow a KFF Health News investigation…

Read More